Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 641–660 of 17,529 recalls

April 24, 2025· KENIL HEALTHCARE PRIVATE LIMITED

Recalled Item: Rapidol

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 24, 2025· KENIL HEALTHCARE PRIVATE LIMITED

Recalled Item: KOFAL

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 24, 2025· KENIL HEALTHCARE PRIVATE LIMITED

Recalled Item: Cinnafresh anticavity gel toothpaste

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 24, 2025· KENIL HEALTHCARE PRIVATE LIMITED

Recalled Item: CURA HONGOS

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
April 23, 2025· BRS Analytical Services, LLC

Recalled Item: Artificial Tears Ophthalmic Solution

The Issue: cGMP deviations and lack of assurance of sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 23, 2025· BRS Analytical Services, LLC

Recalled Item: Carboxymethylcellulose Sodium Ophthalmic Gel 1%

The Issue: cGMP deviations and lack of assurance of sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 23, 2025· BRS Analytical Services, LLC

Recalled Item: Polyvinyl Alcohol Ophthalmic Solution 1.4%

The Issue: cGMP deviations and lack of assurance of sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 23, 2025· BRS Analytical Services, LLC

Recalled Item: Lubricant Eye Drops Solution

The Issue: cGMP deviations and lack of assurance of sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 23, 2025· BRS Analytical Services, LLC

Recalled Item: Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%

The Issue: cGMP deviations and lack of assurance of sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 22, 2025· RemedyRePack Inc.

Recalled Item: Clindamycin HCl Capsule

The Issue: CGMP Deviations - products manufactured in a shared

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 21, 2025· Mckesson Medical-Surgical Inc. Corporate Office

Recalled Item: EVENITY

The Issue: CGMP Deviations; potential temperature excursions due to transit

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 21, 2025· Mckesson Medical-Surgical Inc. Corporate Office

Recalled Item: BENLYSTA (belimumab) for injection

The Issue: CGMP Deviations; potential temperature excursions due to transit

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 21, 2025· Mckesson Medical-Surgical Inc. Corporate Office

Recalled Item: PROLIA (denosumab)

The Issue: CGMP Deviations; potential temperature excursions due to transit

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 21, 2025· Eugia US LLC

Recalled Item: Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL)

The Issue: Out-of-Specification test results were obtained in at long

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 21, 2025· Eugia US LLC

Recalled Item: Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL)

The Issue: Out-of-Specification test results were obtained in at long

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 18, 2025· FDC Limited

Recalled Item: Timolol Maleate Ophthalmic Solution USP

The Issue: Defective Container: Unable to get the solution out

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 18, 2025· American Regent, Inc.

Recalled Item: niCARdipine Hydrochloride Injection

The Issue: Lack of sterility assurance: Product leakage around the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 18, 2025· American Regent, Inc.

Recalled Item: niCARdipine Hydrochloride Injection

The Issue: Lack of sterility assurance: Product leakage around the

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 18, 2025· Preferred Pharmaceuticals, Inc.

Recalled Item: Clindamycin Hydrochloride Capsules

The Issue: cGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
April 17, 2025· Amneal Pharmaceuticals, LLC

Recalled Item: Ropivacaine Hydrochloride Injection

The Issue: Presence of Particulate Matter

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund